MINIREVIEW
Huntington’s disease: degradation of mutant huntingtin by autophagy
Article first published online: 15 JUL 2008
DOI: 10.1111/j.1742-4658.2008.06562.x
© 2008 The Authors Journal compilation © 2008 FEBS
Additional Information
How to Cite
Sarkar, S. and Rubinsztein, D. C. (2008), Huntington’s disease: degradation of mutant huntingtin by autophagy. FEBS Journal, 275: 4263–4270. doi: 10.1111/j.1742-4658.2008.06562.x
Publication History
- Issue published online: 7 AUG 2008
- Article first published online: 15 JUL 2008
- (Received 29 February 2008, accepted 9 May 2008)
- Abstract
- Article
- References
- Cited By
Keywords:
- autophagy;
- Huntington's disease;
- lithium;
- mTOR;
- polyglutamine;
- rapamycin
Autophagy is a nonspecific bulk degradation pathway for long-lived cytoplasmic proteins, protein complexes, or damaged organelles. This process is also a major degradation pathway for many aggregate-prone, disease-causing proteins associated with neurodegenerative disorders, such as mutant huntingtin in Huntington’s disease. In this review, we discuss factors regulating the degradation of mutant huntingtin by autophagy. We also report the growing list of new drugs/pathways that upregulate autophagy to enhance the clearance of this mutant protein, as autophagy upregulation may be a tractable strategy for the treatment of Huntington’s disease.

1742-4658/asset/olbannerleft.gif?v=1&s=9011db155cccc04ee73e143039b3ec555aa8d349)
1742-4658/asset/olbannerright.gif?v=1&s=8ef64c2fc7142c262292a103cebc627d9bc4459b)
